After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases

Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Reumatologia clinica 2019-09, Vol.15 (5), p.e33-e35
Hauptverfasser:	Mateos Rodríguez, Javier José, Bellido, David, Castro, David, Portillo Sánchez, José, Vanegas, Raúl, Núñez García, Alicia
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Acenocoumarol - therapeutic use Adult Anticoagulants - therapeutic use Antiphospholipid Syndrome - drug therapy Carotid Artery Thrombosis - diagnostic imaging Factor Xa Inhibitors - therapeutic use Humans International Normalized Ratio Male Rivaroxaban - therapeutic use Treatment Outcome Venous Thromboembolism - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Antiphospholipid syndrome is characterized by abortions or thrombotic phenomena associated with specific antibodies. Anticoagulant therapy is based on vitamin K antagonists. We present two cases in which the use of rivaroxaban achieved control of the disease after the failure of acenocoumarol.
ISSN:	1885-1398 2173-5743
DOI:	10.1016/j.reuma.2017.04.010